10 results  1 of 1 

1 Real-World Evidence of Trastuzumab, Pertuzumab, and Docetaxel Combination as a First-Line Treatment for Korean Patients with HER2-Positive Metastatic Breast Cancer
Yong-Pyo Lee, Min-Sang Lee, HongSik Kim, Ji-Yeon Kim, Jin Seok Ahn, Young-Hyuck Im, Yeon Hee Park
Cancer Res Treat.2022;54(4):1130-1137.   Published online 2022 January 17     DOI: http://dx.doi.org/10.4143/crt.2021.1103
      
2 Randomized Open Label Phase III Trial of Irinotecan Plus Capecitabine versus Capecitabine Monotherapy in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane: PROCEED Trial (KCSG BR 11-01)
In Hae Park, Seock-Ah Im, Kyung Hae Jung, Joo Hyuk Sohn, Yeon Hee Park, Keun Seok Lee, Sung Hoon Sim, Kyong-Hwa Park, Jee Hyun Kim, Byung Ho Nam, Hee-Jun Kim, Tae-Yong Kim, Kyung-Hun Lee, Sung-Bae Kim, Jin-Hee Ahn, Suee Lee, Jungsil Ro
Cancer Res Treat.2019;51(1):43-52.   Published online 2018 February 14     DOI: http://dx.doi.org/10.4143/crt.2017.562
      
3 Safety Results and Analysis of Eribulin Efficacy according to Previous Microtubules-Inhibitors Sensitivity in the French Prospective Expanded Access Program for Heavily Pre-treated Metastatic Breast Cancer
Renaud Sabatier, Véronique Diéras, Xavier Pivot, Etienne Brain, Henri Roché, Jean-Marc Extra, Audrey Monneur, Magali Provansal, Carole Tarpin, François Bertucci, Patrice Viens, Christophe Zemmour, Anthony Gonçalves
Cancer Res Treat.2018;50(4):1226-1237.   Published online 2017 December 28     DOI: http://dx.doi.org/10.4143/crt.2017.446
      
4 Detection of Circulating Tumor Cells in Breast Cancer Patients Using Cytokeratin-19 Real-Time RT-PCR
Hyung Seok Park, Hyun Ju Han, Soohyeon Lee, Gun Min Kim, Seho Park, Yeon A Choi, Jeong Dong Lee, Gi Moon Kim, Joohyuk Sohn, Seung Il Kim
Yonsei Med J.2017;58(1):19-26.   Published online 2016 November 7     DOI: http://dx.doi.org/10.3349/ymj.2017.58.1.19
      
5 An Open-Label, Randomized, Parallel, Phase III Trial Evaluating the Efficacy and Safety of Polymeric Micelle-Formulated Paclitaxel Compared to Conventional Cremophor EL-Based Paclitaxel for Recurrent or Metastatic HER2-Negative Breast Cancer
In Hae Park, Joo Hyuk Sohn, Sung Bae Kim, Keun Seok Lee, Joo Seop Chung, Soo Hyeon Lee, Tae You Kim, Kyung Hae Jung, Eun Kyung Cho, Yang Soo Kim, Hong Suk Song, Jae Hong Seo, Hun Mo Ryoo, Sun Ah Lee, So Young Yoon, Chul Soo Kim, Yong Tai Kim, Si Young Kim, Mi Ryung Jin, Jungsil Ro
Cancer Res Treat.2017;49(3):569-577.   Published online 2016 September 12     DOI: http://dx.doi.org/10.4143/crt.2016.289
      
6 Efficacy of Letrozole as First-Line Treatment of Postmenopausal Women with Hormone Receptor–Positive Metastatic Breast Cancer in Korea
Seung Hoon Beom, Jisu Oh, Tae-Yong Kim, Kyung-Hun Lee, Yaewon Yang, Koung Jin Suh, Hyeong-Gon Moon, Sae-Won Han, Do-Youn Oh, Wonshik Han, Tae-You Kim, Dong-Young Noh, Seock-Ah Im
Cancer Res Treat.2017;49(2):454-463.   Published online 2016 August 23     DOI: http://dx.doi.org/10.4143/crt.2016.259
      
7 The Correlation of Serum HER-2/neu and CA15-3 in Patients with Metastatic Breast Cancer
Nae-Kyeong Park, Hee-Doo Woo, Doo-Min Sohn, Sung-Yong Kim, Cheol-Wan Lim, Tae-Youn Choi, Jae-Jun Kim, Min-Hyuk Lee
J Breast Cancer.2008;11(1):18-24.   Published online 2008 March 31     DOI: http://dx.doi.org/10.4048/jbc.2008.11.1.18
      
8 The Efficacy of Oral Combination Chemotherapy of 5'-DFUR and Cyclophosphamide for Metastatic Breast Cancer
Min Ho Park, Jung Han Yoon, Young Jong Jegal
J Breast Cancer.2006;9(3):249-253.   Published online 2006 September 30     DOI: http://dx.doi.org/10.4048/jbc.2006.9.3.249
      
9 Serum HER2 as a Response Indicator to Various Chemotherapeutic Agents in Tissue HER2 Positive Metastatic Breast Cancer
Sun-Young Kong, Do Hoon Lee, Eun Sook Lee, Susan Park, Keun Seok Lee, Jungsil Ro
Cancer Res Treat.2006;38(1):35-39.   Published online 2006 February 28     DOI: http://dx.doi.org/10.4143/crt.2006.38.1.35
      
10 The Pattern of Systemic Failure and Factors Influencing on the Outcome after Distant Metastastasis in Breast Cancer
Kyung Ho Park, Seung Il Kim, Seung Sang Ko, Byeong Woo Park, Kyong Sik Lee
J Korean Breast Cancer Soc.2003;6(2):109-116.   Published online 2003 June 30     DOI: http://dx.doi.org/10.4048/jkbcs.2003.6.2.109
      

 1 of 1